6 companies produce vitamin & mineral premix (animal nutrition grade).
dsm-firmenich AG(DSFIR.AS)
HQ CH35% share
dsm-firmenich AG (Kaiseraugst, Basel-Land, Switzerland; formed by merger of DSM NV Netherlands and Firmenich SA Geneva, completed May 2023; combined revenue ~€12B of which fragrance ~€3-4B) is the world's third-largest fragrance company. Firmenich (private, Geneva; founded 1895 by Philippe Chuit and Martin Naef) was the world's largest private fragrance house and the only major fragrance company to remain independent until the DSM merger. Firmenich's fragrance heritage includes Chanel No. 5 (Firmenich supplies the fragrance compound to Chanel — one of the most carefully guarded commercial relationships in the fragrance industry; the Chanel No. 5 formula is a Firmenich-originated formula from 1921). DSM contributed nutrition, health, and biosciences (vitamins, carotenoids, animal feed enzymes) to the merger. The combined dsm-firmenich operates manufacturing at Geneva (Switzerland), Haverhill (UK), Neuvy-sur-Barangeon (France), and Florham Park (USA). The Firmenich name is retained in the merged entity's fragrance operations branding.
dsm-firmenich Animal Nutrition & Health
HQ CH30% share
dsm-firmenich (Kaiseraugst, Switzerland; Euronext Amsterdam: DSFIR; formed 2023 merger of DSM and Firmenich; ~€14B revenue) is the world's largest manufacturer of vitamins for human nutrition, animal nutrition, and dietary supplements. The Animal Nutrition & Health division (formerly DSM Nutritional Products) accounts for approximately 30% of global animal nutrition vitamin market. Produces Vitamins A, D3, E, K, B1 (thiamine), B2 (riboflavin), B5, B6, B9 (folic acid), B12, C, and the carotenoids beta-carotene and canthaxanthin. Manufacturing sites include Sisseln (Switzerland, flagship; Vitamin E and carotenoids), Ludwigshafen (Germany, Vitamin A), Dalry (Scotland UK, Vitamin B12), and Anji (Zhejiang, China, Vitamin C and B-vitamins). Premix customers include major pet food manufacturers — Hill's Pet Nutrition, Royal Canin (Mars), Purina (Nestlé), Blue Buffalo — who source their AAFCO-qualifying vitamin packages from DSM or through toll premixers using DSM APIs.
BASF Animal Nutrition (BASF SE)
HQ DE18% share
BASF SE (Ludwigshafen, Germany; XETRA: BAS; ~€69B revenue) is the world's largest chemical company and a major global vitamin manufacturer through its Animal Nutrition division. BASF produces Vitamin E (as Luphia — dl-alpha-tocopheryl acetate), Vitamin A palmitate, beta-carotene, and canthaxanthin for animal feed and premix manufacturers. BASF Nutrition & Health (Ludwigshafen) includes the Verbund-integrated vitamin synthesis operations at Ludwigshafen. BASF competes directly with dsm-firmenich as a second major Western source of fat-soluble vitamins (A, D, E, K) and provides an alternative to the dominant dsm-firmenich for pet food premix formulators. BASF holds a significant market share in Vitamin E (tocopherols and tocopheryl acetate), where BASF and dsm-firmenich together dominate non-Chinese supply. BASF's Abomasum (Vitamin A synthesis) leverages BASF's integrated isoprenoid chemistry — the same terpene chemistry that produces Vitamin A also produces citral, linalool, and fragrance raw materials.
Trouw Nutrition (Nutreco subsidiary)
HQ NL12% share
Trouw Nutrition (Amersfoort, Netherlands; subsidiary of Nutreco N.V., which is owned by SHV Holdings N.V., a Dutch private conglomerate; Nutreco ~€6B revenue) is one of the world's largest premix manufacturers for livestock and pet food, with approximately 30+ premix production facilities across 25 countries. Trouw Nutrition's premix business includes the Nutrex brand (Europe), Hendrix Voeders, and Selko feed additives. Premix operations source vitamin APIs predominantly from dsm-firmenich and BASF, and mineral salts from global commodity suppliers, blending to customer-specific AAFCO or FEDIAF specifications. Trouw Nutrition is a 'toll premixer' — it does not manufacture vitamins but blends purchased APIs into finished premix packages. This makes Trouw a chokepoint between API manufacturers (Chinese and European) and brand-name pet food producers. Its production in South America, Asia, and Eastern Europe provides geographic redundancy unavailable to smaller national premixers.
Zhejiang Medicine Co., Ltd.
HQ CN8% share
Zhejiang Medicine Co., Ltd. (Hangzhou, Zhejiang, China; Shanghai Stock Exchange: 600216; ~¥8B revenue) is one of China's largest pharmaceutical and vitamin manufacturers, producing Vitamin E (all-rac-alpha-tocopherol and acetate), Vitamin A, Vitamin D3, and Vitamin C (ascorbic acid) for both human pharmaceutical and animal feed markets. Zhejiang Medicine is part of the dominant Chinese cluster of vitamin API producers that collectively supply 60-90% of global feedstock for vitamins C, D3, and several B-vitamins. Its Vitamin E production (synthetic dl-alpha-tocopherol) directly competes with BASF and dsm-firmenich in the global animal feed premix market. Zhejiang Medicine's Vitamin C (ascorbic acid) is sold under the Weishida brand and has been implicated in the 2005-2012 US court case (In re Vitamin C Antitrust Litigation) alleging that Chinese Vitamin C producers coordinated prices and quantities in violation of US antitrust law — the US Second Circuit ruled in 2021 that the coordination was not exempt from US antitrust law, reversing a lower court ruling on foreign sovereign compulsion.
Northeast Pharmaceutical Group Co., Ltd.
HQ CN5% share
Northeast Pharmaceutical Group Co., Ltd. (NEPG; Shenyang, Liaoning, China; Shenzhen Stock Exchange: 000597; ~¥5B revenue; state-controlled) is one of China's largest Vitamin C producers, operating one of the highest-capacity ascorbic acid manufacturing plants in China. NEPG produces Vitamin C (ascorbic acid) API for both pharmaceutical (USP) and food/feed grade markets. Vitamin C is one of the two water-soluble vitamins (with thiamine) most critical to feline health in pet food premixes — cats cannot synthesize vitamin C independently. NEPG was one of the companies named in the In re Vitamin C Antitrust Litigation in US federal courts, where a jury found in 2013 that Chinese Vitamin C producers had coordinated to fix prices and limit exports to the US; the Second Circuit reversed in 2016, the Supreme Court remanded, and the Second Circuit ruled for plaintiffs in 2021 — the longest-running international antitrust dispute over a commodity vitamin in US legal history.